Cargando…

Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children

BACKGROUND: Streptococcus salivarius K12 is an oral probiotic strain releasing two lantibiotics (salivaricin A2 and salivaricin B) that antagonize the growth of S. pyogenes, the most important bacterial cause of pharyngeal infections in humans also affected by episodes of acute otitis media. S. sali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Pierro, Francesco, Colombo, Maria, Zanvit, Alberto, Risso, Paolo, Rottoli, Amilcare S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928062/ https://www.ncbi.nlm.nih.gov/pubmed/24600248 http://dx.doi.org/10.2147/DHPS.S59665

Ejemplares similares

Positive clinical outcomes derived from using Streptococcus salivarius K12 to prevent streptococcal pharyngotonsillitis in children: a pilot investigation
por: Di Pierro, Francesco, et al.
Publicado: (2016)

Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study
por: Di Pierro, Francesco, et al.
Publicado: (2015)

Group A β-hemolytic streptococcal pharyngotonsillitis outbreak
por: Culqui, Dante R, et al.
Publicado: (2014)

Diagnosing streptococcal pharyngotonsillitis in children and adolescents: the limitations of the clinical features
por: Passos, Saulo Duarte
Publicado: (2014)

Diagnosis of streptococcal pharyngotonsillitis in children and adolescents: clinical picture limitations
por: Barbosa, Aurelino Rocha, et al.
Publicado: (2014)

Clinical Effects of Streptococcus salivarius K12 in Hospitalized COVID-19 Patients: Results of a Preliminary Study
por: Di Pierro, Francesco, et al.
Publicado: (2022)

Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media
por: Di Pierro, Francesco, et al.
Publicado: (2012)

Oral use of Streptococcus salivarius K12 in children with secretory otitis media: preliminary results of a pilot, uncontrolled study
por: Di Pierro, Francesco, et al.
Publicado: (2015)

Inhibitory effects of Streptococcus salivarius K12 on formation of cariogenic biofilm
por: Kim, Hye-Ji, et al.
Publicado: (2023)

Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro
por: Yoo, Hyun‐Jun, et al.
Publicado: (2019)

Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational study
por: Gregori, Giuseppe, et al.
Publicado: (2016)

In vitro Interactions between Streptococcus intermedius and Streptococcus salivarius K12 on a Titanium Cylindrical Surface
por: Vacca, Carla, et al.
Publicado: (2020)

Evaluation of cytokines produced by β-hemolytic streptococcus in acute pharyngotonsillitis()()
por: Leão, Sydney Correia, et al.
Publicado: (2015)

Probiotic Streptococcus salivarius K12 Alleviates Radiation-Induced Oral Mucositis in Mice
por: Wang, Yan, et al.
Publicado: (2021)

Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial
por: Sarlin, Suvi, et al.
Publicado: (2020)

Role of a proprietary propolis-based product on the wait-and-see approach in acute otitis media and in preventing evolution to tracheitis, bronchitis, or rhinosinusitis from nonstreptococcal pharyngitis
por: Di Pierro, Francesco, et al.
Publicado: (2016)

Antimicrobial and Antibiofilm Activity of the Probiotic Strain Streptococcus salivarius K12 against Oral Potential Pathogens
por: Stašková, Andrea, et al.
Publicado: (2021)

Clinical Screening Tools to Diagnose Group A Streptococcal Pharyngotonsillitis in Primary Care Clinics to Improve Prescribing Habits
por: Muthanna, Abdulrahman, et al.
Publicado: (2018)

Pilot study to explore the prophylactic efficacy of oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngo-tonsillar episodes in pediatric patients
por: Marini, Giulia, et al.
Publicado: (2019)

Endocarditis por Streptococcus salivarius: caso clínico
por: Rozo-Ortiz, Edwar J., et al.
Publicado: (2021)

Microencapsulation of Probiotic Streptococcus salivarius LAB813
por: Choudhary, Priyadarshani, et al.
Publicado: (2023)

Lemierre's syndrome: a pharyngotonsillitis complication()()
por: Pinheiro, Pedro Ernesto Barbosa, et al.
Publicado: (2014)

Improvement of Psoriasis Using Oral Probiotic Streptococcus salivarius K-12: a Case–Control 24-Month Longitudinal Study
por: Zangrilli, Arianna, et al.
Publicado: (2022)

Assessment of Efficacy of BLIS-Producing Probiotic K12 for the Prevention of Group A Streptococcus Pharyngitis: a Short Communication
por: Di Pierro, Francesco
Publicado: (2018)

Evaluation of a rapid antigen detection test for the diagnosis of group-A beta-hemolytic Streptococcus in pharyngotonsillitis
por: Subashini, Beula, et al.
Publicado: (2015)

Role of rapid antigen detection test for the diagnosis of group-A ß-hemolytic streptococcus in patients with pharyngotonsillitis
por: Filho, Bernardo Cunha Araujo, et al.
Publicado: (2015)

Role of rapid antigen detection test for the diagnosis of group A beta-hemolytic streptococcus in patients with pharyngotonsillitis
por: Filho, Bernardo Cunha Araujo, et al.
Publicado: (2015)

Genome Sequence of the Oral Probiotic Streptococcus salivarius JF
por: Jia, Fang
Publicado: (2016)

Lemierre syndrome: a rare complication of pharyngotonsillitis()()
por: Noh, Hyun Jin, et al.
Publicado: (2015)

Use of Streptococcus salivarius K12 in supporting the mucosal immune function of active young subjects: A randomised double-blind study
por: Bertuccioli, Alexander, et al.
Publicado: (2023)

Multi-Strain Probiotic Supplementation with a Product Containing Human-Native S. salivarius K12 in Healthy Adults Increases Oral S. salivarius
por: Cernioglo, Karina, et al.
Publicado: (2021)

Complete Genome Sequences of Two Human Oral Microbiome Commensals: Streptococcus salivarius ATCC 25975 and S. salivarius ATCC 27945
por: Butler, Robert R., et al.
Publicado: (2017)

Streptococcus salivarius inhibits immune activation by periodontal disease pathogens
por: MacDonald, Kyle W., et al.
Publicado: (2021)

Streptococcus salivarius Probiotics to Prevent Acute Otitis Media in Children: A Randomized Clinical Trial
por: Sarlin, Suvi, et al.
Publicado: (2023)

The Effect of Pimpinella Anisum and Origanum Vulgare Extracts Against Streptococcus Sanguinis, Streptococcus Mutans, and Streptococcus Salivarius
por: Lavaee, Fatemeh, et al.
Publicado: (2022)

Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial
por: Poorni, Saravanan, et al.
Publicado: (2022)

Abundance, Diversity and Role of ICEs and IMEs in the Adaptation of Streptococcus salivarius to the Environment
por: Lao, Julie, et al.
Publicado: (2020)

Hakuna mycotic aneurysm, Streptococcus salivarius does not always mean “no worries”
por: Ahmad, Saad, et al.
Publicado: (2021)

A 2-year follow-up study of patients with pharyngotonsillitis
por: Pallon, Jon, et al.
Publicado: (2018)

The aetiology of pharyngotonsillitis in adolescents and adults – Fusobacterium necrophorum is commonly found
por: Hedin, K., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mc50kttd1p1dbe3h9035pl2jvm